US Stock MarketDetailed Quotes

CASI CASI Pharmaceuticals

Watchlist
  • 3.1200
  • +0.0500+1.63%
Trading Dec 27 11:10 ET
48.34MMarket Cap-1.40P/E (TTM)

CASI Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-11.82%7.79M
-59.48%3.98M
-59.16%3.41M
-21.41%33.88M
-54.95%6.87M
-13.46%8.84M
14.55%9.82M
-7.89%8.35M
42.89%43.11M
66.62%15.26M
Operating revenue
-11.82%7.79M
-59.48%3.98M
-59.16%3.41M
-21.30%33.88M
-54.95%6.87M
-13.46%8.84M
14.85%9.82M
-7.51%8.35M
43.39%43.05M
67.31%15.26M
Cost of revenue
2.74%3.75M
-52.03%1.91M
-52.55%1.6M
-12.64%13.83M
-34.11%2.82M
-14.10%3.65M
12.28%3.99M
-10.11%3.38M
26.04%15.83M
12.42%4.27M
Gross profit
-22.06%4.05M
-64.57%2.07M
-63.65%1.81M
-26.50%20.05M
-63.06%4.06M
-13.01%5.19M
16.15%5.83M
-6.32%4.97M
54.90%27.28M
105.06%10.99M
Operating expense
16.21%12.13M
-23.22%11.62M
-9.93%11.03M
-15.69%45.33M
-45.15%8.82M
-15.28%10.44M
18.53%15.14M
-2.80%12.24M
1.79%53.77M
-3.45%16.09M
Selling and administrative expenses
31.97%10.61M
-17.20%10.37M
-11.93%8.55M
10.75%41.84M
-2.28%11.57M
-4.47%8.04M
40.40%12.52M
12.85%9.71M
-1.64%37.78M
-6.40%11.84M
-Selling and marketing expense
94.92%4.91M
-8.20%4.43M
-5.70%3.74M
14.83%16.45M
26.07%5.15M
-29.39%2.52M
41.85%4.82M
20.90%3.96M
-2.58%14.33M
-21.40%4.09M
-General and administrative expense
3.26%5.7M
-22.84%5.94M
-16.22%4.81M
8.26%25.39M
-17.21%6.42M
13.86%5.52M
39.51%7.7M
7.89%5.75M
-1.06%23.45M
4.07%7.76M
Research and development costs
-36.60%1.52M
-52.03%1.25M
-2.29%2.48M
-38.35%9.86M
-45.53%2.31M
-38.57%2.4M
-32.12%2.61M
-36.52%2.53M
10.91%16M
5.83%4.25M
Other operating expenses
----
----
----
---6.37M
---5.06M
----
----
----
----
----
Operating profit
-54.06%-8.09M
-2.72%-9.55M
-26.77%-9.22M
4.57%-25.28M
6.59%-4.77M
17.41%-5.25M
-20.07%-9.3M
0.25%-7.27M
24.78%-26.49M
54.88%-5.1M
Net non-operating interest income expense
-137.89%-61K
-139.57%-55K
-130.20%-61K
383.46%614K
330.77%112K
1,338.46%161K
247.50%139K
172.97%202K
-60.44%127K
-56.67%26K
Non-operating interest income
----
----
----
383.46%614K
----
----
----
----
-60.44%127K
----
Total other finance cost
137.89%61K
139.57%55K
130.20%61K
----
----
-1,338.46%-161K
---139K
---202K
----
----
Other net income (expense)
36.32%867K
371.74%2.64M
-119.75%-248K
85.31%-1.63M
89.17%-1.24M
-52.68%636K
-556.81%-973K
206.08%1.26M
-1,069.87%-11.07M
-295.56%-11.44M
Gain on sale of security
434.97%872K
316.50%2.13M
-401.23%-406K
93.26%-381K
108.70%519K
-87.77%163K
-586.14%-982K
93.37%-81K
-194.53%-5.65M
-201.19%-5.97M
Earnings from equity interest
----
----
----
--0
----
----
----
----
--5.33M
----
Special income (charges)
--0
--500K
----
81.37%-2.01M
---2.01M
--0
--0
----
-44.05%-10.78M
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--8.72M
----
-Write off
----
----
----
--2.01M
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
--0
--500K
----
--0
--0
--0
--0
----
-3,066.15%-2.06M
----
Other non- operating income (expenses)
-101.06%-5K
100.00%18K
-88.18%158K
1,636.36%764K
1,668.75%251K
4,200.00%473K
-18.18%9K
3,418.42%1.34M
-92.11%44K
-188.89%-16K
Income before tax
-63.54%-7.28M
31.28%-6.97M
-63.88%-9.53M
29.76%-26.29M
64.32%-5.89M
11.39%-4.45M
-35.26%-10.14M
30.79%-5.81M
-4.43%-37.43M
-206.12%-16.52M
Income tax
0
0
0
-104.09%-81K
-100.05%-1K
0
-80K
0
1.98M
1.98M
Earnings from equity interest net of tax
-7,340.00%-1.12M
--0
--0
94.33%-48K
99.88%-1K
---15K
---15K
---17K
---846K
---846K
Net income
-87.98%-8.4M
30.83%-6.97M
-63.40%-9.53M
34.77%-26.26M
69.54%-5.89M
11.09%-4.47M
-34.39%-10.07M
30.58%-5.83M
-12.32%-40.26M
-258.50%-19.34M
Net income continuous Operations
-87.98%-8.4M
30.83%-6.97M
-63.40%-9.53M
34.77%-26.26M
69.54%-5.89M
11.09%-4.47M
-34.39%-10.07M
30.58%-5.83M
-12.32%-40.26M
-258.50%-19.34M
Minority interest income
0
0
0
-10.30%679K
-16.84%163K
-5.06%169K
-9.63%169K
-9.18%178K
-6.77%757K
-4.85%196K
Net income attributable to the parent company
-81.12%-8.4M
31.98%-6.97M
-58.56%-9.53M
34.32%-26.94M
69.01%-6.06M
10.88%-4.64M
-33.32%-10.24M
30.10%-6.01M
-11.90%-41.01M
-248.81%-19.54M
Preferred stock dividends
22K
Other preferred stock dividends
Net income attributable to common stockholders
-81.12%-8.4M
31.98%-6.97M
-58.56%-9.53M
34.27%-26.96M
68.89%-6.08M
10.88%-4.64M
-33.32%-10.24M
30.10%-6.01M
-11.90%-41.01M
-248.81%-19.54M
Basic earnings per share
-57.14%-0.55
32.47%-0.52
-57.78%-0.71
32.89%-2.02
68.06%-0.46
7.89%-0.35
-37.50%-0.77
27.42%-0.45
-11.90%-3.01
-269.23%-1.44
Diluted earnings per share
-57.14%-0.55
32.47%-0.52
-57.78%-0.71
32.89%-2.02
68.06%-0.46
7.89%-0.35
-37.50%-0.77
27.42%-0.45
-11.90%-3.01
-269.23%-1.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -11.82%7.79M-59.48%3.98M-59.16%3.41M-21.41%33.88M-54.95%6.87M-13.46%8.84M14.55%9.82M-7.89%8.35M42.89%43.11M66.62%15.26M
Operating revenue -11.82%7.79M-59.48%3.98M-59.16%3.41M-21.30%33.88M-54.95%6.87M-13.46%8.84M14.85%9.82M-7.51%8.35M43.39%43.05M67.31%15.26M
Cost of revenue 2.74%3.75M-52.03%1.91M-52.55%1.6M-12.64%13.83M-34.11%2.82M-14.10%3.65M12.28%3.99M-10.11%3.38M26.04%15.83M12.42%4.27M
Gross profit -22.06%4.05M-64.57%2.07M-63.65%1.81M-26.50%20.05M-63.06%4.06M-13.01%5.19M16.15%5.83M-6.32%4.97M54.90%27.28M105.06%10.99M
Operating expense 16.21%12.13M-23.22%11.62M-9.93%11.03M-15.69%45.33M-45.15%8.82M-15.28%10.44M18.53%15.14M-2.80%12.24M1.79%53.77M-3.45%16.09M
Selling and administrative expenses 31.97%10.61M-17.20%10.37M-11.93%8.55M10.75%41.84M-2.28%11.57M-4.47%8.04M40.40%12.52M12.85%9.71M-1.64%37.78M-6.40%11.84M
-Selling and marketing expense 94.92%4.91M-8.20%4.43M-5.70%3.74M14.83%16.45M26.07%5.15M-29.39%2.52M41.85%4.82M20.90%3.96M-2.58%14.33M-21.40%4.09M
-General and administrative expense 3.26%5.7M-22.84%5.94M-16.22%4.81M8.26%25.39M-17.21%6.42M13.86%5.52M39.51%7.7M7.89%5.75M-1.06%23.45M4.07%7.76M
Research and development costs -36.60%1.52M-52.03%1.25M-2.29%2.48M-38.35%9.86M-45.53%2.31M-38.57%2.4M-32.12%2.61M-36.52%2.53M10.91%16M5.83%4.25M
Other operating expenses ---------------6.37M---5.06M--------------------
Operating profit -54.06%-8.09M-2.72%-9.55M-26.77%-9.22M4.57%-25.28M6.59%-4.77M17.41%-5.25M-20.07%-9.3M0.25%-7.27M24.78%-26.49M54.88%-5.1M
Net non-operating interest income expense -137.89%-61K-139.57%-55K-130.20%-61K383.46%614K330.77%112K1,338.46%161K247.50%139K172.97%202K-60.44%127K-56.67%26K
Non-operating interest income ------------383.46%614K-----------------60.44%127K----
Total other finance cost 137.89%61K139.57%55K130.20%61K---------1,338.46%-161K---139K---202K--------
Other net income (expense) 36.32%867K371.74%2.64M-119.75%-248K85.31%-1.63M89.17%-1.24M-52.68%636K-556.81%-973K206.08%1.26M-1,069.87%-11.07M-295.56%-11.44M
Gain on sale of security 434.97%872K316.50%2.13M-401.23%-406K93.26%-381K108.70%519K-87.77%163K-586.14%-982K93.37%-81K-194.53%-5.65M-201.19%-5.97M
Earnings from equity interest --------------0------------------5.33M----
Special income (charges) --0--500K----81.37%-2.01M---2.01M--0--0-----44.05%-10.78M----
-Less:Impairment of capital assets --------------0------------------8.72M----
-Write off --------------2.01M------------------0----
-Gain on sale of property,plant,equipment --0--500K------0--0--0--0-----3,066.15%-2.06M----
Other non- operating income (expenses) -101.06%-5K100.00%18K-88.18%158K1,636.36%764K1,668.75%251K4,200.00%473K-18.18%9K3,418.42%1.34M-92.11%44K-188.89%-16K
Income before tax -63.54%-7.28M31.28%-6.97M-63.88%-9.53M29.76%-26.29M64.32%-5.89M11.39%-4.45M-35.26%-10.14M30.79%-5.81M-4.43%-37.43M-206.12%-16.52M
Income tax 000-104.09%-81K-100.05%-1K0-80K01.98M1.98M
Earnings from equity interest net of tax -7,340.00%-1.12M--0--094.33%-48K99.88%-1K---15K---15K---17K---846K---846K
Net income -87.98%-8.4M30.83%-6.97M-63.40%-9.53M34.77%-26.26M69.54%-5.89M11.09%-4.47M-34.39%-10.07M30.58%-5.83M-12.32%-40.26M-258.50%-19.34M
Net income continuous Operations -87.98%-8.4M30.83%-6.97M-63.40%-9.53M34.77%-26.26M69.54%-5.89M11.09%-4.47M-34.39%-10.07M30.58%-5.83M-12.32%-40.26M-258.50%-19.34M
Minority interest income 000-10.30%679K-16.84%163K-5.06%169K-9.63%169K-9.18%178K-6.77%757K-4.85%196K
Net income attributable to the parent company -81.12%-8.4M31.98%-6.97M-58.56%-9.53M34.32%-26.94M69.01%-6.06M10.88%-4.64M-33.32%-10.24M30.10%-6.01M-11.90%-41.01M-248.81%-19.54M
Preferred stock dividends 22K
Other preferred stock dividends
Net income attributable to common stockholders -81.12%-8.4M31.98%-6.97M-58.56%-9.53M34.27%-26.96M68.89%-6.08M10.88%-4.64M-33.32%-10.24M30.10%-6.01M-11.90%-41.01M-248.81%-19.54M
Basic earnings per share -57.14%-0.5532.47%-0.52-57.78%-0.7132.89%-2.0268.06%-0.467.89%-0.35-37.50%-0.7727.42%-0.45-11.90%-3.01-269.23%-1.44
Diluted earnings per share -57.14%-0.5532.47%-0.52-57.78%-0.7132.89%-2.0268.06%-0.467.89%-0.35-37.50%-0.7727.42%-0.45-11.90%-3.01-269.23%-1.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.